TABLAS PARA RESUMEN “ESTUDIO CLINICO DE 972 PACIENTES REUMATOLÓGICOS CON

SÍNDROME DE HIPERLAXITUD ARTICULAR (SHA), USANDO CRITERIO DE BRIGHTON”

 

 

TABLES FOR THE ”CLINICA L STUDY OF 972 RHEUMATOLOGICAL PATIENTS WITH

JOINT HYPERMOBILITY SYNDROME (JHS) USING THE BRIGHTON CRITERIA”

 

 

 

Summary

Total Patients

972

 

 

 

 

Males

216

22,22

Females

756

77,78

 

972

100,00

 

 

 

Table 1

 

 

 

Total

   Males  22.2%

  Females 77.8%

Age Ranges

 n

From 12 to 29 y/o

170

17,49

50

23,15

120

15,87

From 30 to 40 y/o

385

39,61

75

34,72

310

41,01

Older than 50 y/o

417

42,90

91

42,13

326

43,12

 

972

100,00

216

100,00

756

100,00

 


Table 2

 

Beighton Score (BSc)

Total

M

F

 

n

%

n

n

BSc 1

Elbows

297

30,6

48

237

BSc 2

Thumb - Forearm

127

13,1

21

108

BSc 3

MCPs

592

60,9

103

480

BSc 4

Genu-Recurvatum

230

23,7

33

179

BSc 5

Hands flat on floor

638

65,6

103

537

 

 

 

 

 

 

Brighton  Criteria (MC Mayor criteria)

MC 1

BSc 4/9 or higher

383

39,4

58

325

MC 2

Arthralgias > 3 months

27

2,8

103

537

Brighton  Criteria (Mc Minor criteria)

Mc 1

BSc of 3/9 or lower *

554

57,0

141

411

Mc 2

Arthralgias < 3 months

630

64,8

114

519

 

Back problems

690

71,0

140

550

Mc 3

Subluxations

237

24,4

57

188

Mc 4

Recurrent Tendinitis, bursitis

569

58,5

123

455

Mc 5

Marfanoid Habitus

150

15,4

62

95

Mc 6

Skin Alterations

929

95,6

198

742

Mc 7

Myopia

231

23,8

51

181

Mc 7

Dropping eye lids

124

12,8

24

102

Mc 8

Varicose veins

196

20,2

36

158

Mc 8

Hernias

138

14,2

48

87

Mc 8

Uterine/ rectal Prolapse

66

6,8

7

62

Mc 9

MVP

34

3,5

7

25

Mc 10

Family history

554

57,0

141

411

*  Brighton Criteria Major 1 and Minor 1, and Major 2 and Minor 2, are mutually exclusive

Negative Beighton Score( 3/9 or less)

596/972

61,3%

Importance:  The sole use of the Beighton Score, would have excluded 61,3% of the patients

 


 

 

Table 3

 

Low BMD in patients with JHS depending on sex, including all ages

 

Total group

        Males

               Females

                                    n

%

        n                %

         n             %

 

 

 

 

 

 

 

Normal

178

29,1

20

17,1

158

32,0

Osteopenia:   Mild

103

16,9

20

17,1

83

16,8

Moderate

114

18,7

25

21,4

89

18,0

Severe

83

13,6

16

13,7

67

13,6

Osteoporosis

133

21,8

36

30,8

97

19,6

Total studied

611

100,0

117

100,0

494

100,0

 

 

Table 4

BMD depending on age and sex, in 611 patients with JHS, from 12 to 29 y/o

 

                            Total group

    Males

    Females

 

n

%

   n              %

 

   n             %

 

 

 

 

 

 

 

 

Normal

178

29,1

5

23,8

21

35,6

Osteopenia:      Milld

103

16,9

5

23,8

9

15,3

Moderate

114

18,7

6

28,6

11

18,6

Severe

83

13,6

1

4,8

7

11,9

Osteoporosis

133

21,8

4

19,0

11

18,6


Table 5

 

Dysautonomia in the total group

                         Total

group

Males

Females

                             n  

      n                 %

   n           %

 Dysaut. present

349

35,9

39

18,06

310

41,01

Total studied

972

100,00

216

100,00

756

100,00

 

 

Table 6

 

Dysautonomia depending on age and sex, in patients from 12 to 29 y/o

 

Total 

group

Males

Females

 

n

%

   n            %

    n             %

Dysaut. present

349

35,9

20

40,0

77

64,2

Total studied

972

100,00

50

100,00

120

100,00

 

 

Table 7

 

Dysautonomia depending on age, both sexes together

 

Total 

group 

Group A

Group B

Group C

 

 

 

From 12 to 29 y/o

From 30 to 49 y/o

50 y/o and older

 

n

%

    n            %

n            %

   n            %

Dysaut. present

349

35,9

97

57,1

177

46,0

75

18,0

Total studied

972

100,00

170

100,00

385

100,00

417

100,00

 


 

Table 8

 

Blue sclera depending on sex

SCLERA

     Total

 group

Males

Females

 

n

%

       n                %

    n            %

0

190

20,0

72

35.12

118

15.90

I

417

44,0

106

51.71

311

41.91

II

315

33,2

26

12.68

289

38.95

III

26

2,7

1

0.49

24

3.24

 Total studied

948

100,0

205

100.0

742

100.0

 

 

SANTIAGO,  JULY 19, 2007